GO:1905673 positive regulation of lysosome organization: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905673 describes any process that activates or increases the frequency, rate or extent of lysosome organization, a biological_process annotation in the Gene Ontology.
• Lysosome organization is spatially and temporally controlled, and its positive regulation is required for endolysosomal cargo flux, autophagic clearance and cellular proteostasis.
• Phosphoinositide lipids such as PI(3)P and PI(4)P act as membrane landmarks that recruit effector proteins to endolysosomal compartments and help drive lysosome organization.
• Dysregulated positive regulation of lysosome organization is linked to lysosomal storage diseases, neurodegeneration and cardiomyopathy, as shown by newborn screening and clinical case studies.
• Key experimental handles include lysosomal hydrolases (CTSK), autophagy receptors (OPTN), kinases (AURKA) and endolysosomal trafficking regulators.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of candidate regulators of lysosome organization in relevant cell types.
Description
GO:1905673, positive regulation of lysosome organization, is a Gene Ontology biological_process term that captures any process which activates or increases the frequency, rate or extent of lysosome organization. Lysosome organization encompasses the biogenesis, maturation, positioning and functional maintenance of lysosomes and lysosome-related organelles, and its positive regulation ensures that cells can match degradative capacity to changing metabolic and stress conditions. Because lysosomes sit at the endpoint of endocytic, phagocytic and autophagic routes, regulators of lysosome organization influence cargo degradation, nutrient sensing and membrane homeostasis. Research on this term is motivated by the observation that lysosomal dysfunction is a shared feature of many human disorders, including lysosomal storage diseases identified through newborn screening programs and neurodegenerative conditions such as Alzheimer's disease. Experimental work in neurons has shown that endolysosomal compartments and Aurora kinase A participate in the regulation of amyloid beta protein levels, directly connecting positive regulation of lysosome organization to disease-relevant proteostasis. Similarly, signaling pathways such as STING-OPTN-TBK1 influence mitophagy and cytoprotection, illustrating how organelle quality-control programs intersect with lysosomal organization. For researchers, GO:1905673 provides a precise annotation target when studying genes that increase lysosome number, size, acidification, positioning or catalytic activity. The term is also useful for interpreting omics and imaging data, because positive regulators can act at multiple nodes, including phosphoinositide metabolism, hydrolase delivery, cytoskeletal transport and transcriptional programs. This article summarizes the definition, mechanism, key genes, disease links and CRISPR-based methods relevant to GO:1905673.
positive regulation of lysosome organization At A Glance
| GO ID | GO:1905673 |
|---|---|
| GO term | positive regulation of lysosome organization |
| Ontology | biological_process |
| Definition | Any process that activates or increases the frequency, rate or extent of lysosome organization. |
| Synonym | activation of lysosome organization; positive regulation of lysosome organisation; up regulation of lysosome organization; upregulation of lysosome organization and biogenesis |
| Major function | Enhances lysosome biogenesis, maturation, positioning and degradative capacity |
| Related cellular context | Endolysosomal system, autophagic flux, phosphoinositide signaling |
| Representative regulators | PI(3)P/PI(4)P effectors, OPTN, CTSK, AURKA, endosomal trafficking machinery |
| Disease relevance | Lysosomal storage diseases, neurodegeneration, cardiomyopathy |
What Is GO:1905673?
In plain terms, GO:1905673 means any biological process that boosts lysosome organization. The QuickGO definition states: Any process that activates or increases the frequency, rate or extent of lysosome organization. It is a positive regulatory node rather than a structural component, and it is classified under biological_process. Synonyms include activation of lysosome organization, positive regulation of lysosome organisation, up regulation of lysosome organization and upregulation of lysosome organization and biogenesis. The term is used when a gene product or pathway enhances the assembly, maturation, positioning or functional capacity of lysosomes, as opposed to directly being a lysosomal protein.
Why Is positive regulation of lysosome organization Important in Cell Biology?
Positive regulation of lysosome organization is important because lysosomes are central to protein, lipid and organelle turnover, and cells must rapidly adjust lysosomal capacity during nutrient stress, infection and differentiation. Defects in this regulation contribute to lysosomal storage diseases detected by newborn screening and to age-related neurodegenerative pathologies such as Alzheimer's disease. Moreover, pharmacological or genetic modulation of lysosomal organization can alter disease phenotypes, as illustrated by hydroxychloroquine-induced cardiomyopathy and by astrocyte rescue experiments in Alzheimer's disease models. Therefore, GO:1905673 is a high-value annotation for mechanistic studies, drug target discovery and biomarker development.
• Controls autophagic and endocytic cargo clearance, which is essential for cellular proteostasis.
• Determines lysosomal acidification, hydrolase content and degradative efficiency.
• Links phosphoinositide signaling to membrane trafficking and organelle identity.
• Modulates neuronal amyloid beta levels and endolysosomal dynamics in Alzheimer's disease models.
• Participates in cytoprotective mitophagy through STING-OPTN-TBK1 signaling.
• Is relevant to lysosomal storage diseases identified by newborn screening.
• Can be perturbed by drugs such as hydroxychloroquine, causing cardiomyopathy.
• Supports osteoclast function and condylar morphogenesis via hypoxic lysosome regulation.
• Provides a mechanistic entry point for CRISPR screens targeting lysosome regulators.
• Offers candidate targets for therapies aimed at enhancing lysosomal clearance in neurodegeneration.
What Happens During positive regulation of lysosome organization?
Initiation by membrane and phosphoinositide signals
In simple terms: The process often starts when specific lipids on endosomal membranes recruit helper proteins.
Positive regulation of lysosome organization frequently begins with the generation or recognition of phosphoinositide landmarks such as PI(3)P and PI(4)P on endosomal and lysosomal membranes. Recombinant biosensors have enabled multiplex and super-resolution imaging of these phosphoinositides, revealing their spatial organization during endolysosomal maturation. These lipid signals recruit effector proteins that initiate downstream steps of lysosome organization, including membrane remodeling and cargo sorting.
Endosomal maturation and cargo flux
In simple terms: Endosomes mature into degradative compartments and move cargo toward lysosomes.
During endosomal maturation, spatial regulation of endosomes in growing dendrites illustrates how trafficking pathways deliver cargo to lysosomes in polarized cells. Positive regulation of lysosome organization increases the frequency and rate of these maturation events, supporting efficient endolysosomal flux. Endolysosomal compartments also participate in regulating amyloid beta protein levels in neurons, showing that maturation is functionally coupled to disease-relevant cargo handling.
Autophagic and mitophagic clearance
In simple terms: The cell recycles damaged components by sending them to lysosomes.
Autophagy and mitophagy converge on lysosomes for degradation. STING-OPTN signaling confers cytoprotection through TBK1-dependent mitophagy, a process that requires functional lysosomal organization to complete cargo clearance. Positive regulation of lysosome organization therefore supports the terminal steps of autophagic and mitophagic pathways, and its impairment can lead to accumulation of damaged organelles.
Hydrolase delivery and lysosomal activation
In simple terms: Enzymes are delivered to lysosomes to make them fully degradative.
Lysosomal hydrolases such as cathepsin K (CTSK) are critical for degradative function. Ctsk-positive osteoclasts orchestrate condylar morphogenesis via a hypoxic lysosome pathway, demonstrating that hydrolase delivery and lysosomal activation are developmentally important. Positive regulation of lysosome organization increases the delivery or activity of such hydrolases, enhancing the degradative capacity of the compartment.
Positioning and functional maintenance
In simple terms: Lysosomes must be in the right place and kept functional over time.
Lysosome positioning and maintenance are influenced by cytoskeletal transport and by signaling pathways that respond to cellular stress. In hippocampal astrocytes from an Alzheimer's disease mouse model, stabilizing ER-mitochondrial interactions at a 20 nm distance rescued protein dyshomeostasis, a process that depends on organelle cross-talk and lysosomal function. Positive regulation of lysosome organization thus includes mechanisms that maintain lysosome number, location and activity over time.
Key Genes Involved in GO:1905673 positive regulation of lysosome organization
The following genes and proteins have been experimentally linked to lysosome organization, endolysosomal trafficking or related regulatory pathways and are useful entry points for studying GO:1905673.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PIK3C3 | Generates PI(3)P on endosomal membranes | Phosphoinositide biosensor imaging of endolysosomal maturation |
| PIK3C2A | Produces PI(3)P and PI(4)P pools | Super-resolution imaging of phosphoinositide dynamics |
| OPTN | Autophagy receptor in STING-OPTN-TBK1 mitophagy | Cytoprotection and mitophagy studies |
| TBK1 | Kinase downstream of STING-OPTN signaling | Mitophagy and lysosomal clearance assays |
| CTSK | Lysosomal cysteine protease in osteoclasts | Condylar morphogenesis and hypoxic lysosome models |
| AURKA | Aurora kinase A regulating endolysosomal amyloid beta | Neuronal amyloid beta level control |
| APP | Amyloid precursor protein processed in endolysosomes | Alzheimer's disease endolysosomal studies |
| MAPT | Microtubule-associated protein tau | Neurodegeneration and lysosomal trafficking context |
| SQSTM1 | Autophagy receptor p62 | Cargo recognition for lysosomal degradation |
| LAMP1 | Lysosomal membrane protein | Lysosome abundance and positioning marker |
| LAMP2 | Lysosomal membrane protein | Lysosomal storage disease and maturation marker |
| TFEB | Transcription factor controlling lysosomal biogenesis | Transcriptional regulation of lysosome organization |
| GBA1 | Lysosomal glucocerebrosidase | Lysosomal storage disease and neurodegeneration |
| NPC1 | Lysosomal cholesterol transporter | Lysosomal storage disease newborn screening |
| CTNS | Cystinosin lysosomal cystine transporter | Lysosomal storage disease newborn screening |
| IDUA | Alpha-L-iduronidase lysosomal enzyme | Mucopolysaccharidosis newborn screening |
| GLA | Alpha-galactosidase A lysosomal enzyme | Fabry disease newborn screening |
How Is positive regulation of lysosome organization Regulated?
Positive regulation of lysosome organization is controlled at multiple levels. Transcriptionally, TFEB and related factors drive expression of lysosomal and autophagic genes, increasing lysosomal capacity in response to stress. At the membrane level, phosphoinositide pools generated by PI3K complexes recruit effector proteins that initiate endolysosomal maturation, and biosensors have revealed the spatial and temporal dynamics of these lipids. Signaling pathways such as STING-OPTN-TBK1 regulate mitophagy and cytoprotection, indirectly influencing lysosomal demand and organization. In neurons, Aurora kinase A activity modulates endolysosomal regulation of amyloid beta levels, providing an example of kinase-dependent control. Additionally, hypoxic conditions can shape lysosomal programs in osteoclasts, as shown for CTSK-positive cells during condylar morphogenesis. Together, these layers allow cells to tune lysosome organization to metabolic, immune and developmental cues.
positive regulation of lysosome organization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GBA1 | Gaucher disease and Parkinson's risk | Knockout and point-mutation iPSC-derived neurons |
| NPC1 | Niemann-Pick type C | Knock-in disease variants in hepatic or neuronal cells |
| CTSK | Condylar morphogenesis and osteoclast biology | Ctsk knockout osteoclast cultures |
| APP | Alzheimer's disease amyloid pathology | Overexpression in neuronal cell lines |
| LAMP2 | Danon disease cardiomyopathy | Knockout cardiomyocytes |
Lysosomal storage diseases
Lysosomal storage diseases arise from defects in lysosomal enzymes or transporters, and newborn screening programs in Japan have demonstrated the feasibility of early detection for several of these disorders. Genes such as GBA1, NPC1, CTNS, IDUA and GLA are directly linked to lysosomal function, and their dysfunction impairs the organization and degradative capacity of lysosomes. Positive regulation of lysosome organization is therefore relevant to understanding compensatory responses and to developing therapies that enhance residual lysosomal activity.
Neurodegeneration and Alzheimer's disease
Endolysosomal dysfunction is increasingly recognized in Alzheimer's disease. In neurons, endolysosomes and Aurora kinase A participate in the regulation of amyloid beta protein levels, linking lysosome organization to amyloid pathology. In hippocampal astrocytes from an Alzheimer's disease mouse model, stabilizing ER-mitochondrial interactions rescued protein dyshomeostasis, a process that depends on organelle cross-talk and lysosomal function. These findings suggest that positive regulation of lysosome organization may be protective in neurodegenerative contexts.
Cardiomyopathy and drug-induced lysosomal stress
Hydroxychloroquine, a drug that affects lysosomal function, has been associated with cardiomyopathy in a clinical case report. This illustrates that perturbing lysosomal organization can have serious consequences in cardiac tissue. Understanding positive regulation of lysosome organization may help identify mechanisms of drug-induced lysosomal stress and potential protective strategies.
Craniofacial and skeletal development
Ctsk-positive osteoclasts orchestrate condylar morphogenesis via a hypoxic lysosome pathway, indicating that lysosomal organization in osteoclasts contributes to skeletal development. Dysregulation of this process could affect craniofacial morphogenesis, making GO:1905673 relevant to developmental biology and skeletal disease research.
From positive regulation of lysosome organization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene reduce lysosome organization? | CRISPR knockout in HeLa or iPSC-derived cells |
| Does a disease-associated variant alter lysosomal function? | Point-mutation knock-in of the variant |
| Does tagging a protein affect its localization to lysosomes? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression increase lysosomal capacity? | Doxycycline-inducible overexpression |
| Which genes regulate lysosome organization genome-wide? | CRISPR library screening with lysosomal reporters |
| How does a regulator affect autophagic flux? | Knockout plus LC3 flux assays |
How to Study the positive regulation of lysosome organization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoinositide biosensor imaging | PI(3)P and PI(4)P distribution | Endolysosomal maturation studies |
| LC3 flux assay | Autophagic degradation rate | Knockout validation |
| Mitophagy reporter | Mitochondrial clearance | STING-OPTN-TBK1 studies |
| Lysosomal pH and activity assays | Acidification and enzyme activity | Hydrolase function |
| Proteomics | Lysosomal protein composition | Hydrolase profiling |
| RNA-seq | Transcriptional lysosomal programs | TFEB target analysis |
| CRISPR library screening | Genome-wide regulators | Discovery of positive regulators |
| Super-resolution microscopy | Nanoscale organelle contacts | ER-mitochondria-lysosome cross-talk |
Imaging phosphoinositides and lysosomes
Recombinant biosensors enable multiplex and super-resolution imaging of phosphoinositides, allowing researchers to visualize PI(3)P and PI(4)P dynamics during endolysosomal maturation. Combining these biosensors with lysosomal markers such as LAMP1 provides spatial information about positive regulation of lysosome organization.
Autophagic and mitophagic flux assays
LC3 turnover and mitophagy reporters measure the functional output of lysosomal degradation. STING-OPTN-TBK1 signaling studies have used such assays to link mitophagy to cytoprotection. These methods are essential for determining whether a candidate regulator increases lysosome organization in a functional sense.
Proteomics and hydrolase profiling
Mass spectrometry-based proteomics can quantify lysosomal hydrolases and membrane proteins, revealing changes in lysosomal content. Cathepsin K (CTSK) studies in osteoclasts illustrate how hydrolase profiling connects to developmental phenotypes. Such data complement transcriptomic analyses of lysosomal gene programs.
CRISPR screening and bioinformatics
Genome-wide CRISPR screens with lysosomal reporters can identify positive regulators of lysosome organization. Hits can be prioritized using pathway enrichment and network analysis, and validated with knockout or overexpression models. Bioinformatics integration of transcriptomic and proteomic data helps distinguish direct regulators from downstream effects.
How CRISPR Can Be Used to Study GO:1905673 positive regulation of lysosome organization
Knockout
CRISPR knockout of candidate genes is used to test whether they are required for positive regulation of lysosome organization. For example, knocking out OPTN or TBK1 can impair mitophagy and lysosomal clearance, providing causal evidence. Knockout of CTSK in osteoclasts can reveal defects in lysosomal function during morphogenesis.
Point Mutation
Point-mutation knock-in allows modeling of disease-associated variants in lysosomal genes. Variants in GBA1, NPC1 or CTNS identified through newborn screening can be introduced into cell lines to assess their impact on lysosome organization. This approach distinguishes loss-of-function from gain-of-function effects.
Knock-in
Tagged knock-in of lysosomal proteins such as LAMP1 or LAMP2 enables live-cell imaging of lysosome positioning and abundance. Knock-in of fluorescent reporters for phosphoinositides can also be used to track lipid dynamics during lysosome organization.
Overexpression
Overexpression of positive regulators, such as TFEB or activated STING-OPTN pathway components, can increase lysosomal capacity and clearance. Overexpression models are useful for testing sufficiency, while knockout models test necessity.
How EDITGENE Supports positive regulation of lysosome organization Research
Researchers studying positive regulation of lysosome organization-related genes often need to determine whether a candidate gene is causally involved in lysosome biogenesis, maturation or function. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbations in relevant cell types, from knockout to knock-in and overexpression, supported by library screening and bioinformatics.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of lysosome organization research.
Frequently Asked Questions About positive regulation of lysosome organization
What is GO:1905673?
GO:1905673 is the Gene Ontology term for positive regulation of lysosome organization, defined as any process that activates or increases the frequency, rate or extent of lysosome organization.
What does positive regulation of lysosome organization mean in simple terms?
It means any cellular process that boosts the assembly, maturation or function of lysosomes.
What genes are involved in positive regulation of lysosome organization?
Genes such as TFEB, OPTN, TBK1, CTSK, AURKA, LAMP1, LAMP2, GBA1, NPC1, CTNS, IDUA and GLA have been linked to lysosomal function and organization.
How is lysosome organization regulated?
It is regulated by transcription factors like TFEB, phosphoinositide signaling, kinase pathways such as STING-OPTN-TBK1, and developmental cues including hypoxia.
Why is positive regulation of lysosome organization important in disease?
Dysregulation contributes to lysosomal storage diseases, neurodegeneration, cardiomyopathy and skeletal developmental defects.
What methods are used to study lysosome organization?
Common methods include phosphoinositide biosensor imaging, LC3 flux assays, mitophagy reporters, proteomics, RNA-seq and CRISPR screens.
Can CRISPR be used to study lysosome organization?
Yes, CRISPR knockout, point-mutation knock-in, tagged knock-in and overexpression models are widely used to test causal roles of candidate genes.
What diseases are linked to lysosomal organization defects?
Lysosomal storage diseases, Alzheimer's disease, hydroxychloroquine-induced cardiomyopathy and craniofacial morphogenesis defects have been associated with lysosomal dysfunction.
How do phosphoinositides regulate lysosome organization?
PI(3)P and PI(4)P on endosomal membranes recruit effector proteins that drive endolysosomal maturation and lysosomal organization.
What cell models are suitable for studying GO:1905673?
iPSC-derived neurons, osteoclasts, cardiomyocytes, hepatic cells and HeLa cells with lysosomal reporters are suitable models.
Conclusion
GO:1905673, positive regulation of lysosome organization, is a biologically important process that integrates phosphoinositide signaling, autophagic flux, hydrolase delivery and organelle positioning. Its dysregulation is linked to lysosomal storage diseases, neurodegeneration, cardiomyopathy and developmental defects, making it a compelling target for mechanistic and therapeutic research. CRISPR-based models, combined with imaging, proteomics and bioinformatics, provide powerful tools to dissect the regulators of this process. EDITGENE offers end-to-end services to generate knockout, point-mutation, knock-in and overexpression cell models, as well as library screening and bioinformatics support, to accelerate discovery in this field.
References
- 1. Maib H et al.. 2024. Recombinant biosensors for multiplex and super-resolution imaging of phosphoinositides.. J Cell Biol 223(6) PMID: 38578646
- 2. Onuki T et al.. 2025. Japanese experience of newborn screening for lysosomal storage diseases and adrenoleukodystrophy.. Orphanet J Rare Dis 20(1):373 PMID: 40708026
- 3. Yap CC et al.. 2022. Spatial regulation of endosomes in growing dendrites.. Dev Biol 486:5-14 PMID: 35306006
- 4. Huang ZB et al.. 2026. STING-OPTN signaling confers cytoprotection through TBK1-dependent mitophagy.. Cell Rep 45(6):117515 PMID: 42268710
- 5. Tang Y et al.. 2026. Ctsk(+) Osteoclasts Orchestrate Condylar Morphogenesis via Hypoxic Lysosome.. J Dent Res 105(5):626-636 PMID: 41108121
- 6. Dematteis G et al.. 2025. Rescue of protein dyshomeostasis in hippocampal astrocytes from an Alzheimer's disease mouse model by stabilizing ER-mitochondrial interactions at a 20 nm distance.. Alzheimers Res Ther 17(1):148 PMID: 40615914
- 7. Hussein A et al.. 2025. Hydroxychloroquine-Induced Cardiomyopathy: A Case Report.. Cureus 17(1):e77763 PMID: 39981461
- 8. Afghah Z et al.. 2024. Involvement of Endolysosomes and Aurora Kinase A in the Regulation of Amyloid β Protein Levels in Neurons.. Int J Mol Sci 25(11) PMID: 38892390
